Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature-Reference-Cited by-同舟云学术

Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature

Published:2019-06-03 Issue: Volume: Page:e12928
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Diotallevi Federico¹^ORCID,Campanati Anna¹,Radi Giulia¹,Brisigotti Valerio¹,Molinelli Elisa¹,Brancorsini Donatella²,Offidani Annamaria¹

Affiliation:

1. Dermatological Clinic Department of Clinical and Molecular SciencesPolytechnic University of the Marche Region Ancona Italy

2. Institute of Pathological Anatomy and HistopathologyPolytechnic University of the Marche Region Ancona Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12928

Reference13 articles.

1. Systematic review: IBD‐associated pyoderma gangrenosum in the biologic era, the response to therapy;Agarwal A.;Alimentary Pharmacology & Therapeutics,2013

2. Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis;Arivarasan K.;Intestinal Research,2016

3. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%;Bellini V.;Journal of the European Academy of Dermatology and Venereology,2008

4. Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial;Brooklyn T. N.;Gut.,2006

5. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor‐α inhibitors: Results of a retrospective analysis;Campanati A.;International Journal of Dermatology,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review;International Journal of Molecular Sciences;2023-10-26

2. Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum;Annals of Dermatology;2023

3. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments;American Journal of Clinical Dermatology;2022-05-24

4. Successful switching treatment of adalimumab for refractory pyoderma gangrenosum in a patient with rheumatoid arthritis with prior use of tumour necrosis factor inhibitors: A case report and review of the literature;Modern Rheumatology Case Reports;2022-03-12

5. Choosing the right biologic for complications of inflammatory bowel disease;Expert Review of Gastroenterology & Hepatology;2022-02-06